Concepedia

Erik Yusko

EY

Statistics

Publications

31

Citations

3.8K

H-Index

23

Active since

2016

Affiliations

Adaptive Biotechnologies (United States)(Current)

Fred Hutch Cancer Center

Center for Cancer Research

National Institutes of Health

The University of Texas MD Anderson Cancer Center

Erik Yusko is an author at Adaptive Biotechnologies (United States) specializing in immunology, oncology, and cancer immunology.

Publications per year

2016–2023

31

Publications

31

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth et al. · Cancer Immunology Research · 2016 · 493 citations · Full text

Medicine, Immunology, Oncology +17

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 426 citations

Medicine, Immunology, Oncology +12

Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade

Simon J. Dovedi, Eleanor J. Cheadle, Amy L. Popple et al. · Clinical Cancer Research · 2017 · 367 citations · Full text

Medicine, Immunology, Oncology +17

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

Alexandra Snyder, Tavi Nathanson, Samuel A. Funt et al. · PLoS Medicine · 2017 · 367 citations · Full text

Life Sciences, Immunology, Oncology +17

TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence

Alexandre Reuben, Rachel M. Gittelman, Jianjun Gao et al. · Cancer Discovery · 2017 · 236 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 31